...
首页> 外文期刊>Heart rhythm: the official journal of the Heart Rhythm Society >Utility of a novel watch-based pulse detection system to detect pulselessness in human subjects
【24h】

Utility of a novel watch-based pulse detection system to detect pulselessness in human subjects

机译:基于手表的新型脉冲检测系统在人类受试者中检测无脉搏​​的实用性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The Wriskwatch is a novel, watch-based pulse detection device that detects the loss of a radial pulse via advanced pulse detection technology and immediately contacts emergency medical systems. Objective: The purpose of this first-in-man, prospective, single-blinded, phase 1 study was to evaluate the ability of this device to detect motionlessness and pulselessness in human subjects as a simulation of sudden cardiac death. Methods: The study cohort consisted of 34 patients: 24 hospitalized patients and 10 presenting for implantable cardioverter-defibrillator (ICD) testing. We simulated loss of pulse in our hospitalized patients via blood pressure cuff inflation to occlude the brachial arterial pulse at random times in 20 subjects with no inflations in 4 while the patients were instructed to keep perfectly still. Of the 10 patients undergoing ventricular fibrillation (VF) induction during ICD testing, the exact times of VF induction were recorded. A blinded reviewer determined if and when motion and pulse were lost in all patients using only data from the device. Results: Of the 34 patients, 2 had an unusable signal, 1 had device ejection during ICD testing, and 2 had too much motion artifact and were excluded (5/34 patients, or 14.7% of the total cohort). Of the 29 remaining subjects, 4 had no loss of pulse of which the device correctly identified 3. In the remaining 25 patients, the device correctly identified the time of pulselessness in 23 of 25 (16/17 hospitalized patients and 7/8 ICD patients). Overall, the Wriskwatch was worn for a total of 561.2 minutes. Pulselessness was present for 5.8 minutes. The sensitivity of the watch to detect pulse status (based on 15-second intervals) was 99.9%, and the specificity was 90.3%. Conclusion: The Wriskwatch is a novel device that shows promise as a tool to hasten activation of emergency medical systems and facilitate early defibrillation in patients with cardiac arrest.
机译:背景:Wriskwatch是一种新型的基于手表的脉冲检测设备,可通过先进的脉冲检测技术检测径向脉冲的丢失,并立即与紧急医疗系统联系。目的:这项第一人称,前瞻性,单盲,第1期研究的目的是评估该设备检测人类受试者静止不动和无脉动的能力,以模拟心源性猝死。方法:该研究队列由34例患者组成:24例住院患者和10例正在接受植入式心脏复律除颤器(ICD)测试。我们模拟了通过血压袖带充气住院患者的脉搏损失,以随机随机阻塞20名受试者的肱动脉脉搏,在4名患者中没有发生充气,同时指示患者保持完全静止。在ICD测试期间接受心室纤颤(VF)诱导的10例患者中,记录了VF诱导的确切时间。盲法检查者仅使用设备的数据确定所有患者是否以及何时丢失运动和脉搏。结果:34例患者中,有2例信号不可用,有1例在ICD测试中出现装置弹出,有2例运动伪影过多,被排除在外(5/34例患者,占总队列的14.7%)。在剩下的29位受试者中,有4位没有脉搏丢失,该装置可以正确识别3例。在其余25位患者中,该装置可以正确识别25位中的23位(16/17住院患者和7/8 ICD患者)中的无脉搏时间)。总体而言,Wriskwatch佩戴时总计561.2分钟。无脉冲持续5.8分钟。手表检测脉搏状态的灵敏度(基于15秒间隔)为99.9%,特异性为90.3%。结论:Wriskwatch是一种新颖的设备,显示出有望作为一种工具来加快紧急医疗系统的激活并促进心脏骤停患者的早期除颤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号